Rexall Ibuprofen
- Product NDC
- 55910-685
- 11-digit product format
- 559100685
- Labeler code
- 55910
- Product ID
- 55910-685_e623eadd-a3af-4781-812c-3f88893131f2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Ibuprofen
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Dolgencorp, LLC
- Application
- ANDA074937
- Marketing category
- ANDA
- Marketing start
- 2010-08-19
- Substance
- IBUPROFEN
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rexall Ibuprofen
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| IBUPROFEN | 100 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WK2XYI10QM |
| Rxcui | 197803 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55910-685-26 | Rexall Ibuprofen | 1 in 1 CARTON | SUSPENSION | 1 | | 5 |
| 55910-685-26 | Rexall Ibuprofen | 118 mL in 1 BOTTLE | SUSPENSION | 118 | | 5 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55910-685 | REXALL IBUPROFEN (IBUPROFEN) SUSPENSION [DOLGENCORP, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20230619_d2dc2f71-c0cb-4e6d-85b9-fcf386e207a0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55910-685-26 | 55910068526 | 1 BOTTLE in 1 CARTON (55910-685-26) / 118 mL in 1 BOTTLE | 1 bottle | 2010-08-19 | 0000-00-00 | No | No | Current |